TLR4 and metabolic dysfunction-associated steatohepatitis: Additionally, the notion that increased hepatic TLR4 expression in NASH indicates an important role of portal endotoxemia may be inappropriate since TLRs are activated by several molecules other than LPS, including palmitic acid[40].